Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
92.91
+0.83 (0.90%)
Aug 13, 2025, 4:00 PM - Market closed
Medtronic Revenue
In the fiscal year ending April 25, 2025, Medtronic had annual revenue of $33.54B with 3.62% growth. Medtronic had revenue of $8.93B in the quarter ending April 25, 2025, with 3.94% growth.
Revenue (ttm)
$33.54B
Revenue Growth
+3.62%
P/S Ratio
3.56
Revenue / Employee
$353,021
Employees
95,000
Market Cap
119.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 25, 2025 | 33.54B | 1.17B | 3.62% |
| Apr 26, 2024 | 32.36B | 1.14B | 3.64% |
| Apr 28, 2023 | 31.23B | -459.00M | -1.45% |
| Apr 29, 2022 | 31.69B | 1.57B | 5.21% |
| Apr 30, 2021 | 30.12B | 1.20B | 4.16% |
| Apr 24, 2020 | Pro | Pro | Pro |
| Apr 26, 2019 | Pro | Pro | Pro |
| Apr 27, 2018 | Pro | Pro | Pro |
| Apr 28, 2017 | Pro | Pro | Pro |
| Apr 29, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
MDT News
- 1 day ago - Former Medtronic Supply Chain Leader Joins FourKites' Strategic Advisory Council - Business Wire
- 2 days ago - 10 stocks with recently increased dividends — and why they merit a closer look - Market Watch
- 8 days ago - Medtronic to announce financial results for its first quarter of fiscal year 2026 - PRNewsWire
- 9 days ago - More Downside For Medtronic Stock? - Forbes
- 12 days ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 13 days ago - Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewsWire
- 14 days ago - Medtronic: Growth Challenges Persist - Seeking Alpha
- 23 days ago - Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes - PRNewsWire